BioScience Today

@biosciencetoday

Bioscience Today is a contemporary publication written for decision-makers within the , , and markets.

Vrijeme pridruživanja: ožujak 2014.

Tweetovi

Blokirali ste korisnika/cu @biosciencetoday

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @biosciencetoday

  1. Prikvačeni tweet
    2. lis 2019.

    The latest issue of Bioscience Today is now available. If you would like to subscribe to receive your free print or digital copy of our magazine, visit -

    Poništi
  2. A new ground-breaking project in the fight against life-threatening illnesses has been launched, which will examine and sequence the genetic code of volunteers at the

    Poništi
  3. 31. sij

    Scientists at the have found that an essential protein plays a crucial protective role, guarding against severe damage caused during in cultured human cells

    Poništi
  4. 30. sij

    One researcher working to transform is Professor Pietro Valdastri, Chair in Robotics & Autonomous Systems at the

    Poništi
  5. 29. sij

    Record levels of venture investment, corporate deals, property investment and product development success suggest and research institutions and businesses are thriving, highlights Tony Jones, CEO,

    Poništi
  6. 28. sij

    Professor James Wolffsohn, Chair of Optometry and associate pro-vice-chancellor of , casts a fresh pair of eyes on and explains the role of blinking in relieving symptoms

    Poništi
  7. 27. sij

    We speak to Fabio Kellett, Director of Biosimilars at Napp Pharmaceuticals Ltd about the development of and how they are enabling more patients to be treated

    Poništi
  8. 24. sij

    New figures show that the uptake of best value lowered costs to taxpayers by £294 million last year alone, on track to meet 's target of a further £400 million annual savings by 2021

    Poništi
  9. 23. sij

    Scientists at the are developing a new wave of drugs to combat – thanks to a £7.4 million boost

    Poništi
  10. 21. sij

    survival in the UK has improved since 1995, although it still lags behind other high-income countries, according to new analysis by the International Cancer Benchmarking Partnership

    Poništi
  11. 19. sij

    Engaging patients as early as possible in the clinical development process increases the chances of success explains Dr William Van’t Hoff, a Clinical Director in the

    Poništi
  12. 18. sij

    According to the data obtained by WACD, the global air cargo brand increased its tonnage rate by 7.1 per cent and grew substantially across the industry which shrank by 5.1 per cent

    Poništi
  13. 17. sij

    Dr Gernot Walko, explains in more detail about his British Skin Foundation funded research and what he hopes it can achieve

    Poništi
  14. 16. sij

    Migratory animals are actively adjusting their traditions to climate change, new research has found

    Poništi
  15. 15. sij

    The £200 million whole genome sequencing project is being created, forming a partnership of pharmaceutical firms and health experts which will examine and sequence the of 500,000 volunteers at the UK Biobank, based in Stockport

    Poništi
  16. 13. sij

    medicines are playing an important role in providing choice for clinicians and increasing access for patients by driving down cost to the

    Poništi
  17. 12. sij

    The BSc (Hons) (pathology lab-based) degree apprenticeship has expanded rapidly over the past couple of years

    Poništi
  18. 11. sij

    Dr Jason Bellia, Senior Patent Examiner at , looks at two routes – one to deliver nucleic acids across cell membranes and another looking to harness paracellular absorption to deliver biologics

    Poništi
  19. 10. sij

    Many companies that protect their inventions, brands or product designs in their home country, do not realise that this does not give them automatic protection in other countries

    Poništi
  20. 31. pro 2019.

    In this issue we hear from Sarah Montague about a trial engaging homeless people in research.

    Poništi
  21. 30. pro 2019.

    The study is researching the introduction of a cheaper biosimilar medicine for inflammatory and autoimmune diseases such as rheumatoid arthritis and axial spondyloarthritis.

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·